Päivi M. Paldánius

Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial

David R. Matthews, Päivi M. Paldánius, Pieter Proot et al. · The Lancet · 2019 · 355 citations

Medicine, Pharmacology, Pharmacotherapy +16

Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study

W. David Strain, Valentina Lukashevich, Wolfgang Kothny et al. · The Lancet · 2013 · 139 citations

Pharmacy, Geriatric Medicine, Pharmacotherapy +15

Time to do more: Addressing clinical inertia in the management of type 2 diabetes mellitus

W. David Strain, Xavier Cos, Michael Hirst et al. · Diabetes Research and Clinical Practice · 2014 · 111 citations · Full text

Medicine, Communication, Internal Medicine +17

Clinical Inertia in Individualising Care for Diabetes: Is There Time to do More in Type 2 Diabetes?

W. David Strain, Matthias Blüher, Päivi M. Paldánius · Diabetes Therapy · 2014 · 75 citations · Full text

Medicine, Pharmacotherapy, Diabetology +9

Suppressed Bone Turnover in Obesity: A Link to Energy Metabolism? A Case-Control Study

Heli Viljakainen, Kaisa K. Ivaska, Päivi M. Paldánius et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 68 citations · Full text

Medicine, Biochemistry, Endocrinology +17